Mycophenolate mofetil is antifibrotic at low but profibrogenic at higher clinical doses in the Mdr2-/- mouse model of liver fibrosis

被引:0
|
作者
Popov, Yury
Millonig, Gunda
Khokhar, Asim
Zaks, Jessica
Bhaskar, Killimangalam
Sverdlov, Deanna
Schuppan, Detlef
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A826 / A826
页数:1
相关论文
共 47 条
  • [1] Lack of efficacy of rapamycin as an antifibrotic agent in the Mdr2-/- model of liver fibrosis
    Bridle, K. R.
    Sobbe, A.
    Jaskowski, L.
    De Guzman, C. E.
    Santrampurwala, N.
    Fletcher, L.
    Crawford, D. H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 4 - 5
  • [2] PRE-CLINICAL EVALUATION OF THE ANTIFIBROTIC EFFICACY OF A FORMULATION OF DEFINED NATURALLY OCCURING ANTIOXIDANTS IN THE MDR2-/- MOUSE MODEL OF BILIARY FIBROSIS
    Popov, Yury
    Zoks, Jessica
    Sverdlov, Deanna Y.
    Eisenberg, David
    Zabrecky, George P.
    Narula, Acharan S.
    Schuppan, Detlef
    HEPATOLOGY, 2008, 48 (04) : 922A - 923A
  • [3] The antifibrotic effect of low dose rapamycin is diminished in Mdr2-/- when administered to animals with advanced hepatic fibrosis
    Sobbe, A. L.
    Bridle, K. R.
    Fletcher, L. M.
    Crawford, D. H. G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A302 - A303
  • [4] Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
    Kyritsi, Konstantina
    Francis, Heather
    Zhou, Tianhao
    Ceci, Ludovica
    Wu, Nan
    Yang, Zhihong
    Meng, Fanyin
    Chen, Lixian
    Baiocchi, Leonardo
    Kundu, Debjyoti
    Kennedy, Lindsey
    Liangpunsakul, Suthat
    Wu, Chaodong
    Glaser, Shannon
    Alpini, Gianfranco
    GENE EXPRESSION-THE JOURNAL OF LIVER RESEARCH, 2020, 20 (02): : 89 - 103
  • [5] FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
    O'Brien, April
    Zhou, Tianhao
    White, Tori
    Medford, Abigail
    Chen, Lixian
    Kyritsi, Konstantina
    Wu, Nan
    Childs, Jonathan
    Stiles, Danaleigh
    Ceci, Ludovica
    Chakraborty, Sanjukta
    Ekser, Burcin
    Baiocchi, Leonardo
    Carpino, Guido
    Gaudio, Eugenio
    Wu, Chaodong
    Kennedy, Lindsey
    Francis, Heather
    Alpini, Gianfranco
    Glaser, Shannon
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1574 - 1588
  • [6] Blockade of Substance P Receptor attenuates Cellular Senescence and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
    Wan, Ying
    Meng, Fanyin
    McDaniel, Kelly
    Wu, Nan
    Venter, Julie
    Francis, Heather L.
    Zhou, Tianhao
    Standeford, Holly
    Glaser, Shannon
    Alpini, Gianfranco
    GASTROENTEROLOGY, 2016, 150 (04) : S1150 - S1151
  • [7] A New Mdr2-/- Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer
    Ikenaga, Naoki
    Liu, Susan B.
    Sverdlov, Deanna Y.
    Yoshida, Shuhei
    Nasser, Imad
    Ke, Qingen
    Kang, Peter M.
    Popov, Yury
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (02): : 325 - 334
  • [8] 4-METHYLUMBELLIFERONE IMPROVES LIVER STIFFNESS, CHOLANGIOCYTE PROLIFERATION AND FIBROSIS IN THE Mdr2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Kunimoto, Koshi
    Fan, Weiguo
    Li, Yuan
    Dehnad, Ali
    Mozes, Gergely
    Wang, Yanan
    Nagy, Nadine
    Bollyky, Paul
    Torok, Natalie J.
    HEPATOLOGY, 2021, 74 : 740A - 741A
  • [9] Inhibition of hepatic senescence decreases biliary proliferation and liver fibrosis in vitro and in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC).
    Kyritsi, Tina
    Zhou, Tianhao
    Meng, Fanyin
    Wu, Nan
    Venter, Julie
    Giang, Thao
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2017, 66 : 109A - 109A
  • [10] CELL TRANSPLANTATION OF FETAL STEM/PROGENITOR CELLS INTO THE MDR2-/- MOUSE MODEL OF CHRONIC LIVER INJURY
    Schievenbusch, Stephanie
    Schrammel, Tillman
    Goeser, Tobias
    Nierhoff, Dirk
    HEPATOLOGY, 2011, 54 : 695A - 695A